Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T22:47:50.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition-related terminology update, noting that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-21T22:46:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site’s footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T22:48:49.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T22:52:12.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden message, replacing the study details and navigation. This indicates restricted access to the content.
    Difference
    19%
    Check dated 2026-09-23T22:51:57.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page revision tag was bumped from v3.6.6 to v3.7.0, indicating a new deployment of the page. This update does not alter the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-16T22:24:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.